Richard Eskew - Net Worth and Insider Trading

Richard Eskew Net Worth

The estimated net worth of Richard Eskew is at least $299,418 dollars as of 2024-04-28. Richard Eskew is the EVP General Counsel of Accolade Inc and owns about 37,949 shares of Accolade Inc (ACCD) stock worth over $299,418. Details can be seen in Richard Eskew's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Eskew has not made any transactions after 2024-03-04 and currently still holds the listed stock(s).

Transaction Summary of Richard Eskew

To

Richard Eskew Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Eskew owns 1 companies in total, including Accolade Inc (ACCD) .

Click here to see the complete history of Richard Eskew’s form 4 insider trades.

Insider Ownership Summary of Richard Eskew

Ticker Comapny Transaction Date Type of Owner
ACCD Accolade Inc 2024-03-04 EVP General Counsel

Richard Eskew Latest Holdings Summary

Richard Eskew currently owns a total of 1 stock. Richard Eskew owns 37,949 shares of Accolade Inc (ACCD) as of March 4, 2024, with a value of $299,418.

Latest Holdings of Richard Eskew

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACCD Accolade Inc 2024-03-04 37,949 7.89 299,418

Holding Weightings of Richard Eskew


Richard Eskew Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Eskew has made a total of 16 transactions in Accolade Inc (ACCD) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Accolade Inc is the sale of 485 shares on March 4, 2024, which brought Richard Eskew around $4,675.

Insider Trading History of Richard Eskew

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Eskew Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Eskew Ownership Network

Ownership Network List of Richard Eskew

No Data

Ownership Network Relation of Richard Eskew


Richard Eskew Owned Company Details

What does Accolade Inc do?

Who are the key executives at Accolade Inc?

Richard Eskew is the EVP General Counsel of Accolade Inc. Other key executives at Accolade Inc include President Robert N Cavanaugh , Chief Financial Officer Stephen H. Barnes , and director & Chief Executive Officer Rajeev Singh .

Accolade Inc (ACCD) Insider Trades Summary

Over the past 18 months, Richard Eskew made 16 insider transaction in Accolade Inc (ACCD) with a net sale of 6,880. Other recent insider transactions involving Accolade Inc (ACCD) include a net sale of 152,890 shares made by Rajeev Singh , a net sale of 10,386 shares made by Stephen H. Barnes , and a net sale of 11,208 shares made by Robert N Cavanaugh .

In summary, during the past 3 months, insiders sold 7,689 shares of Accolade Inc (ACCD) in total and bought 0 shares, with a net sale of 7,689 shares. During the past 18 months, 187,895 shares of Accolade Inc (ACCD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 187,895 shares.

Accolade Inc (ACCD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Accolade Inc Insider Transactions

No Available Data

Richard Eskew Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Eskew. You might contact Richard Eskew via mailing address: C/o Accolade, Inc., 660 West Germantown Pike, Suite 500, Plymouth Meeting Pa 19462.

Discussions on Richard Eskew

No discussions yet.